Thanks, captainblood and semi retired for your thoughtful and...

Thanks, captainblood and semi retired for your thoughtful and comprehensive commentaries.

A few other thoughts:

A. I note on page 20 of the presentation, "enables up to 90% silicon content as the anode's active material". 90% !! Seems not long ago we thought 15% was pretty good. And here we have "low grade, unrefined silicon". How attractive is that for battery manufacturers?

B. Unrefined? Now here's a stray thought - what is the potential of our technology for all kinds of refining (for purity) in a range of hi-tech industrial uses of various materials - including rare earths?

C. What struck me from my first glance over the presentation, is its emphasis on commercialisation and revenue generation. Critically important to us shareholders as well as to potential customers; both need to be sure that the company is in for the long haul.

D. Page 31: "strategy to add complementary POC technology, and become a global developer of niche and novel diagnostic products and solutions". I have been wondering about our sepsis, troponin and other tests in the pipeline. I am confident their time with AnteoTech will come.

As with many of us, over these last couple of months I have been gritting my teeth while showing a firm upper lip to the outside world. This presentation assures me that all is well. So I dipped in yesterday for a few more.